甲基化和转录组分析构建了一个预后模型,并揭示了VMO1在肺腺癌中抑制作用
Lishui Wang1, Maopeng Yin2, Zeyu Zhang2
1Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, PR China.
Cellular signalling
|July 25, 2024
概括
这项研究确定了肺腺癌 (LUAD) 中95个甲基化驱动基因,并使用三个基因开发了一个预后模型. 该模型预测了患者的风险,与瘤微环境相关,并表明低风险组的免疫治疗反应更好.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 基因组学就是基因组学.
背景情况:
- 基因甲基化是一种关键的表观遗传调节剂.
- 异常的DNA甲基化与瘤的发展和进展有关.
研究的目的:
- 在肺腺癌 (LUAD) 中识别甲基化驱动基因 (MDGs).
- 为 LUAD 风险预测构建一个预后模型.
- 研究VMO1在LUAD进展中的作用及其与瘤微环境的关联.
主要方法:
- 对转录组和DNA甲基化数据的联合分析.
- 用于预后模型构建的单变量和多变量考克斯回归分析.
- 激光测序,RT-qPCR,MTT,迁移和伤口愈合测定用于基因验证和功能研究.
主要成果:
- 在LUAD中确定了95个千年发展目标;开发了3个千年发展目标预测模型 (GMNN,SPINK2,VMO1).
- 风险评分与瘤微环境 (TME) 和临床特征相关.
- 低风险患者表现出更好的免疫治疗反应;VMO1在LUAD细胞中表现出抑制瘤的作用.
结论:
- 为预测LUAD风险建立了一个强大的预后模型.
- 在LUAD中,VMO1充当恶性抑制剂.
- 风险评分和TME之间的联系提供了对瘤发生和潜在治疗点的见解.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
mRNA Stability and Gene Expression
2.8K
2.8K


